Unraveling Key Chloroquine Resistance-Associated Alleles Among Plasmodium falciparum Isolates in South Darfur State, Sudan Twelve Years After Drug Withdrawal

References

• World Health Organization. World Malaria Report 2023. Geneva: WHO; 2023.
   Google Scholar
• Menegon M, Talha AA, Severini C, et al. Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan. Am J Trop Med Hyg. 2010;83(2):250–257.
   PubMed Web of Science ®Google Scholar
• Federal Ministry of Health. Sudan Malaria Indicator Survey, 2016. Khartoum: Communicable and Non-communicable Disease Control Directorate/Federal Ministry of Health; 2017.
   Google Scholar
• Noor AM, ElMardi KA, Abdelgader TM, et al. Malaria risk mapping for control in the Republic of Sudan. Am J Trop Med Hyg. 2012;87(6):1012–1021.
   PubMed Web of Science ®Google Scholar
• Malik EM, Mohamed TA, Elmardi KA, et al. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malar J. 2006;5:65.
   PubMed Web of Science ®Google Scholar
• Omer AH. Response of Plasmodium falciparum in Sudan to oral chloroquine. Am J Trop Med Hyg. 1978;27(5):853–857.
   PubMed Web of Science ®Google Scholar
• Bayoumi RA, Babiker HA, Ibrahim SM, et al. Chloroquine-resistant Plasmodium falciparum in eastern Sudan. Acta Trop. 1989;46(3):157–165.
   PubMed Web of Science ®Google Scholar
• Ibrahim AM, Ali FR, Ali ME. Assessment of chloroquine resistance of Plasmodium falciparum in children of Wad Medani (Central Sudan). J Trop Pediatr. 1992;38(4):162–166.
   PubMed Web of Science ®Google Scholar
• Elkheir HK, Elkarim EF, Eltayeb IB, Elkadaru AE, Babiker HA, Ibrahim AM. Efficacy of sulphadoxine and pyrimethamine, doxycycline and their combination in the treatment of chloroquine resistant falciparum malaria. Saudi Med J. 2001;22(8):690–693.
   PubMed Web of Science ®Google Scholar
• Abdel-Hameed AA, El-Jak IE, Faragalla IA. Sentinel posts for monitoring therapeutic efficacy of antimalarial drugs against Plasmodium falciparum infections in the Sudan. Afr J Med Med Sci. 2001:30. Suppl:1-5
   Google Scholar
• Adam I, Osman ME, Elghzali G, Ahmed GI, Gustafssons LL, Elbashir MI. Efficacies of chloroquine, sulfadoxine-pyrimethamine and quinine in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol. 2004;98(7):661–666.
   PubMed Web of Science ®Google Scholar
• van den Broek IV, Gatkoi T, Lowoko B, Nzila A, Ochong E, Keus K. Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, South Sudan. Trans R Soc Trop Med Hyg. 2003;97(2):229–235.
   PubMed Web of Science ®Google Scholar
• Stivanello E, Cavailler P, Cassano F, et al. Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan. Trop Med Int Health. 2004;9(9):975–980.
   PubMed Web of Science ®Google Scholar
• Malik EM, Ali EM, Mohamed TA, et al. Efforts to control malaria in Sudan - case study of the National Malaria Control Programme, 2001-2005. Italian J Trop Med. 2006;11(3–4):56.
   Google Scholar
• Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6(4):861–871.
   PubMed Web of Science ®Google Scholar
• Plowe CV. Monitoring antimalarial drug resistance: making the most of the tools at hand. J Exp Biol. 2003;206(Pt 21):57.
   Web of Science ®Google Scholar
• Ecker A, Lehane AM, Clain J, Fidock DA. PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 2012;28(11):504–514.
   PubMed Web of Science ®Google Scholar
• Lakshmanan V, Bray PG, Verdier-Pinard D, et al. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO j. 2005;24(13):2294–2305.
   PubMed Web of Science ®Google Scholar
• Tagelsir N, Ibrahim Z, Medani A, et al. High frequency of Plasmodium falciparum PfCRT K76T and PfpghN86Y in patients clearing infection after chloroquine treatment in the Sudan. Acta Trop. 2006;97(1):19–25.
   PubMed Web of Science ®Google Scholar
• Shrivastava SK, Gupta RK, Mahanta J, Dubey ML. Correlation of molecular markers, Pfmdr1-N86Y and Pfcrt-K76T, with in vitro chloroquine resistant Plasmodium falciparum, isolated in the malaria endemic states of Assam and Arunachal Pradesh, Northeast India. PLoS One. 2014;9(8).
   Web of Science ®Google Scholar
• Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol. 2005;56(2):323–333.
   PubMed Web of Science ®Google Scholar
• Ecker A, Lehane AM, Fidock DA. Molecular markers of Plasmodium resistance to antimalarials. In: Staines HM, Krishna S, editors. Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use. Basel: Springer; 2012:245–280.
   Google Scholar
• Mu J, Ferdig MT, Feng X, et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol. 2003;49(4):977–989.
   PubMed Web of Science ®Google Scholar
• Adagu IS, Warhurst DC. Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology. 2001;123(Pt 3):219–224.
   PubMedGoogle Scholar
• Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J Infect Dis. 2001;183(10):1535–1538.
   PubMed Web of Science ®Google Scholar
• Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005;94(3):181–190.
   PubMed Web of Science ®Google Scholar
• Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009;8:89.
   PubMed Web of Science ®Google Scholar
• Hastings IM, Watkins WM, White NJ. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci. 2002;357(1420):505–519.
   PubMed Web of Science ®Google Scholar
• Guerra AP, Olivera MJ, Cortés LJ, Chenet SM, Macedo de Oliveira A, Lucchi NW. Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018. Malar J. 2022;21(1):306.
   PubMed Web of Science ®Google Scholar
• Kublin JG, Cortese JF, Njunju EM, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187(12):1870–1875.
   PubMed Web of Science ®Google Scholar
• Mita T, Kaneko A, Lum JK, et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg. 2003;68(4):413–415.
   PubMed Web of Science ®Google Scholar
• Wang X, Mu J, Li G, et al. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People’s Republic of China. Am J Trop Med Hyg. 2005;72(4):410–414.
   PubMed Web of Science ®Google Scholar
• Laufer MK, Thesing PC, Eddington ND, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006;355(19):1959–1966.
   PubMed Web of Science ®Google Scholar
• Mwai L, Ochong E, Abdirahman A, et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009;8:106.
   PubMed Web of Science ®Google Scholar
• Wurtz N, Fall B, Pascual A, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J. 2012;11:197.
   PubMed Web of Science ®Google Scholar
• Gharbi M, Flegg JA, Hubert V, et al. Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J. 2013;12:35.
   PubMed Web of Science ®Google Scholar
• Das S, Tripathy S, Chattopadhayay S, et al. Progressive increase in point mutations associates chloroquine resistance: even after withdrawal of chloroquine use in India. Int J Parasitol Drugs Drug Resist. 2017;7(3):251–261.
   PubMed Web of Science ®Google Scholar
• Ocan M, Akena D, Nsobya S, et al. Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors. Malar J. 2019;18(1):76.
   PubMedGoogle Scholar
• Warhurst DC, Awad El Kariem FM, Miles MA. Simplified preparation of malarial blood samples for polymerase chain reaction. Lancet. 1991;337(8736):303–304.
   PubMed Web of Science ®Google Scholar
• Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today. 1987;3(8):241–246.
   PubMedGoogle Scholar
• Campbell CC, Chin W, Collins WE, Teutsch SM, Moss DM. Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet. 1979;2(8153):1151–1154.
   PubMed Web of Science ®Google Scholar
• Ochong EO, van den Broek IV, Keus K, Nzila A. Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am J Trop Med Hyg. 2003;69(2):184–187.
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Nair S, Jacobzone C, Zavai A, Balkan S. Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan. Trop Med Int Health. 2003;8(12):1068–1073.
   PubMed Web of Science ®Google Scholar
• Nour BY, Mohamadani AA, Saeed OK, Schallig H. Molecular markers assessment of chloroquine resistance to Plasmodium falciparum isolates in Wad Medani district, Gezira State, Sudan. N M J. 2015;3(17):576.
   Google Scholar
• Hussien M, Abdel Hamid MM, Elamin EA, et al. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017. PLoS One. 2020;15(8):34.
   Web of Science ®Google Scholar
• Abdulla Mohammed WS, Yasin K, Mahgoub NS, Abdel Hamid MM. Cross sectional study to determine chloroquine resistance among Plasmodium falciparum clinical isolates from Khartoum, Sudan. F1000Res. 2018;7:208.
   PubMedGoogle Scholar
• Mohamed AO, Hussien M, Mohamed A, et al. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan. Malar J. 2020;19(1):78.
   PubMedGoogle Scholar
• Lu F, Zhang M, Culleton RL, et al. Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China. Parasit Vectors. 2017;10(1):355.
   PubMedGoogle Scholar
• Abdelgader TM, Ibrahim AM, Elmardi KA, et al. Progress towards implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a cluster-sample survey. BMC Public Health. 2012;12:11.
   PubMed Web of Science ®Google Scholar
• Mohammed A, Ndaro A, Kalinga A, et al. Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malar J. 2013;12:415.
   PubMed Web of Science ®Google Scholar